ArticleEndocrinology2009

Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception.

Amanda Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.